A core component of Immunophotonics’ laser-assisted immunotherapy method is, of course, the laser technology, and Immunophotonics has partnered with Irradia of Sweden to create the MID-Laser CL.

The Immunophotonics MID-Laser CL builds upon Irradia’s proven MID-Laser platform, integrating key elements of the original design along with a unique optical delivery system and application-specific functionality.

The MID-Laser CL delivers the precise amount of laser energy to the target tissue, optimizing the devitalization of tumor cells whilst ensuring minimal damage to surrounding tissues.